AbstractRecent studies have identified new melanoma antigens that are recognised by CD4+ T cells. Analysis of tumour-specific CD4+ T-cell responses may lead to the development of optimal anti-cancer vaccines that can induce an orchestrated effort of tumour-specific CD4+ and CD8+ T cells in the fight against cancer
Cytolytic T-lymphocytes (CTLs) mediate tumour rejection in several animal models. In humans, presumi...
CD8+ T cells represent a subset of adaptive immune cells and have been the central focus of cancer i...
Tumor antigen-specific CD4(+) T cells generally orchestrate and regulate immune cells to provide imm...
AbstractRecent studies have identified new melanoma antigens that are recognised by CD4+ T cells. An...
Recent studies have identified new melanoma antigens that are recognised by CD4+ T cells. Analysis o...
Recent studies have identified new melanoma antigens that are recognised by CD4+ T cells. Analysis o...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Completed under a Cotutelle arrangement between the University of Melbourne and University of Bonn©...
There have been great advances in clinical immunotherapies against cancer over the past two decades....
The goal of tumor immunotherapy is to elicit immune responses against autologous tumors. It would be...
The goal of tumor immunotherapy is to elicit immune responses against autologous tumors. It would be...
This review presents key advances in combining T cell receptor (TCR) gene transfer to redirect T-cel...
Cytolytic T-lymphocytes (CTLs) mediate tumour rejection in several animal models. In humans, presumi...
CD8+ T cells represent a subset of adaptive immune cells and have been the central focus of cancer i...
Tumor antigen-specific CD4(+) T cells generally orchestrate and regulate immune cells to provide imm...
AbstractRecent studies have identified new melanoma antigens that are recognised by CD4+ T cells. An...
Recent studies have identified new melanoma antigens that are recognised by CD4+ T cells. Analysis o...
Recent studies have identified new melanoma antigens that are recognised by CD4+ T cells. Analysis o...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Although recent therapeutic approaches have revitalized the enthusiasm of the immunological way to c...
Completed under a Cotutelle arrangement between the University of Melbourne and University of Bonn©...
There have been great advances in clinical immunotherapies against cancer over the past two decades....
The goal of tumor immunotherapy is to elicit immune responses against autologous tumors. It would be...
The goal of tumor immunotherapy is to elicit immune responses against autologous tumors. It would be...
This review presents key advances in combining T cell receptor (TCR) gene transfer to redirect T-cel...
Cytolytic T-lymphocytes (CTLs) mediate tumour rejection in several animal models. In humans, presumi...
CD8+ T cells represent a subset of adaptive immune cells and have been the central focus of cancer i...
Tumor antigen-specific CD4(+) T cells generally orchestrate and regulate immune cells to provide imm...
DOI
Add to ORKG